FOXO1-mTOR pathway in vascular pericyte regulates the formation of type H vessels to control bone metabolism.

Caiyu Cheng, Mingye Deng, Chubin Cheng, Hangtian Wu, Yutian Wang, Mincheng Lu, Zilong Yao, Kaiqun Li, Xianrong Zhang, Bin Yu

Division of Orthopaedics and Traumatology, Department of Orthopaedics, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, PR China.Division of Orthopaedics and Traumatology, Department of Orthopaedics, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, PR China. · pubmed

Paper

Abstract

As the population aging progresses, age-related osteoporosis has become one of the most common and severe chronic degenerative diseases. Due to insufficient understanding of its complex pathomechanisms, current clinical treatments often suffer from many negative effects. Type H vessels play critical role in bone remodeling owing to their specialized function in coupling angiogenesis and osteogenesis. Increasing evidences have shown a close association between the age-related decline of type H vessels and bone loss. However, the underlying mechanisms whereby the regression of type H vessels with aging remain largely unknown.

The following analysis is generated by AI and may contain errors. It is separate from the authors’ abstract and is not peer review.

Research summary

The paper investigates the FOXO1-mTOR pathway in vascular pericytes and its role in the formation of type H vessels, which are linked to bone metabolism and age-related osteoporosis. This research addresses mechanisms that could underlie age-related decline in bone health, making it relevant to longevity research. However, while it presents solid findings, it does not appear to offer groundbreaking insights that would significantly advance the field, hence the moderate impact score.

Author of this paper? Send a correction.